Safety: Clinical Trials

7 trials for Safety, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7
Phase 21Completed 1

Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents
E4/DRSP 15/3 mg combined tablet - Safety
Phase 3CompletedEstetra1452020-12-282023-12-22
Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B
Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered) - Immunogenicity, Safety
Phase 3CompletedPT Bio Farma2202020-10-132022-01-18
Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.
Test product, Control product - Subjects in Need of a Human Milk Fortifier (HMF), Growth
Phase 2 / Phase 3CompletedNutricia Research2072018-03-082024-09-26
Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age
ATX-101, Placebo - Moderate to Severe Convexity of Submental Fat, Safety
Phase 3CompletedKythera Biopharmaceuticals552014-04-012020-02-17
Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat
Deoxycholic Acid, Placebo - Moderate to Severe Convexity of Submental Fat, Safety
Phase 3CompletedKythera Biopharmaceuticals932014-01-012020-02-17
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
Azilsartan medoxomil and chlorthalidone, Olmesartan medoxomil and hydrochlorothiazide - Safety
Phase 3CompletedTakeda1532011-03-012013-12-13
Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.
13-valent pneumococcal conjugate vaccine - 13-valent Pneumococcal Vaccine, Immunization
Phase 3CompletedPfizer2632010-04-012012-02-08

Narrower conditions

Hypertension (1)  ·  Kidney Diseases (1)  ·  Renal Insufficiency (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Deoxycholic Acid (2)  ·  Chlorthalidone (1)  ·  Control Groups (1)  ·  Hydrochlorothiazide (1)  ·  Olmesartan Medoxomil (1)  ·  azilsartan medoxomil (1)

Sponsors

Kythera Biopharmaceuticals (2)  ·  Estetra (1)  ·  Nutricia Research (1)  ·  PT Bio Farma (1)  ·  Pfizer (1)  ·  Takeda (1)

Countries

France (2)  ·  Germany (2)  ·  Latvia (2)  ·  Netherlands (2)  ·  Poland (2)  ·  United States (2)  ·  Bulgaria (1)  ·  Estonia (1)  ·  Finland (1)  ·  Georgia (1)  ·  Indonesia (1)  ·  Lithuania (1)  ·  Slovakia (1)  ·  Sweden (1)  ·  Ukraine (1)

Top investigators

Frederick Beddingfield, III, MD, PhD (2)  ·  Eddy Fadliyana (1)

Results publications

PMID 29504252, PMID 40037774

NIH funding

2019 (1)